Infectious Disease

Infectious Disease

Infectious diseases kill nearly 10 million people a year; primarily in developing countries, where access to preventive care and treatment is limited. But even in the United States, new strains of disease emerge periodically, which must be addressed quickly and effectively.

Key Initiatives, Research Partners

Grand Challenges in Global Health

Funded by the Bill & Melinda Gates Foundation, Grand Challenges in Global Health encompasses 43 project across 33 countries, working toward scientific breakthroughs to prevent, treat and cure diseases that kill millions each year.

Key Initiatives, Research Partners

MAL-ED: A Global Network for the Study of Malnutrition and Enteric Diseases

Poor nutrition is linked to more than half of all child deaths worldwide. This initiative, funded by the Bill & Melinda Gates Foundation, draws together an international group of scientific investigators to study the inter-relationship between enteric infections and malnutrition to reduce its devastating effects.

Key Initiatives, Research Partners

HIV Vaccine Development

The Foundation for the NIH's portfolio of HIV/AIDS research projects, all part of Gates Foundation's Collaboration for AIDS Vaccine Discovery, is working to expedite development of an effective AIDS vaccine.

Program, Research Partners

HIT-TB: Identification of High-quality HITs for Tuberculosis

The HIT-TB project is a collaboration between the FNIH and the National Institute of Allergy and Infectious Diseases, along with academic institutions in the United Kingdom and South Africa, and is supported by a grant from the Bill & Melinda Gates Foundation. Its focus is on combating tuberculosis, which infects one-third of the world’s population.

Program, Research Partners

Vector-based Control of Transmission: Discovery Research (VCTR)

VCTR logoThe “Vector-based Control of Transmission: Discovery Research” program is an extension of the Grand Challenges in Global Health initiative, aimed at establishing a pipeline of innovative new tools that will be safe, easily deployed, effective and sustainable for u

Program, Research Partners

Centralized Envelope Comparative Immunogenicity Study (CECI)

This project aims to address a fundamental problem blocking the development of a successful HIV-1 vaccine. The goal is to understand how best to design T cell immunogens to address the broad genetic diversity of HIV-1.

Donate button

Related News
FNIH Awards Nearly $6 Million in Grants for Malaria Control Research
Consortium Assembled to Design Human Trials of Mosaic HIV Vaccine